Go to startpage A world-leading medical solutions company Current: Our leadership team OUR GOVERNANCE Our leadership team Our Board and operational leadership team drive the company forward. PRESIDENT AND CHIEF EXECUTIVE OFFICER Zlatko Rihter Zlatko Rihter is a Swedish national and joined Mölnlycke in November 2020 as the President and CEO of Mölnlycke Health Care AB. He has extensive experience from the healthcare sector after having spent more than 20 years within the industry. Prior to joining Mölnlycke, he was President and CEO of Sweden-based CellaVision, a world-leading provider of digital solutions for medical microscopy in the field of hematology, listed on Nasdaq Nordic. Previous positions include EVP Sales & Marketing at ORIGIO, as well as President GBU Chronic at Gambro and Director Patient Handling Product Division at ArjoHuntleigh. Business Areas EXECUTIVE VICE PRESIDENT BUSINESS AREA OR SOLUTIONS Anders Andersson Anders is responsible for our focused OR (Operating Room) Solutions organization within the Mölnlycke Procedure Trays, staff clothing and drapes product ranges. Anders has been with the company since 2000. During the years with Mölnlycke he has held various senior roles in Operations, Commercial and R&D. Before taking on his current role, he was Vice President of Global Manufacturing and EVP OR Solutions. EXECUTIVE VICE PRESIDENT BUSINESS AREA GLOVES Katriina Öberg Katriina, a Finnish national, has grown her career with Mölnlycke since she joined in 1999. During her years at the company, she has held various senior leadership roles in our global and regional Commercial businesses, within both marketing and sales. Most recently she was Regional Vice President APAC stationed in Singapore, where she moved after holding General Manager position in Region North. EXECUTIVE VICE PRESIDENT BUSINESS AREA ANTISEPTICS Lina Karlsson Lina Karlsson leads our Antiseptics business. She joined Mölnlycke in April 2019 as head of ORS R&D, with a broad medtech and pharma background, much of which was at Gambro and Baxter. She has held senior global positions in R&D and Operations, with responsibility for a range of projects, including customer-focused innovation, cost optimisation, quality improvements, organisational development and integrations. EXECUTIVE VICE PRESIDENT BUSINESS AREA WOUND CARE Rob Claypoole Rob is a US national and joined Mölnlycke in March 2017 as President, US. He was previously at Medtronic where he held various leadership roles including Global GM, Soft Tissue Repair and Global GM, Obesity & Metabolic Health and Executive Vice President Commercial. Before Medtronic, Rob held various marketing roles with increasing responsibility at Johnson & Johnson’s Vision Care division. Corporate Functions CHIEF MEDICAL OFFICER & EXECUTIVE VICE PRESIDENT REGULATORY AND QUALITY AFFAIRS Emma Wright British national Emma Wright joined Mölnlycke in 2018. As our Chief Medical Officer, she is responsible for Clinical Affairs, Medical Affairs and Health Economics. She also leads the Regulatory Affairs and Quality Assurance teams. Emma has spent her entire career in medical devices, particularly in the wound care and surgical implant space. She has worked across various markets, for a range of medtech businesses, from start-ups to large global companies. CHIEF OPERATIONS OFFICER AND EXECUTIVE VICE PRESIDENT SUSTAINABILITY Eric De Kesel Eric has been with the company since 2002 and has held roles as GM of our factory in Waremme, Belgium, as well as heading up various business units within our commercial organisation. Before taking on his current role, he was President of the Surgical Division and later Executive Vice President, Operations & RQA. EXECUTIVE VICE PRESIDENT, LEGAL Kristin Hedlund Kristin Hedlund is a Swedish national and joined the Executive team in 2018. Before taking on her current role at Mölnlycke she held a number of positions within DB Schenker. Most recently she served as General Counsel and member of the Board at Schenker AB. Kristin has more than twenty years of experience in Legal affairs. At Mölnlycke she is responsible for the Legal function and coordinates compliance-related activities in support of the execution of our strategy. EXECUTIVE VICE PRESIDENT, CHIEF PEOPLE & COMMUNICATIONS OFFICER Martin Lexa Martin joined Mölnlycke in 2016. He has many years of experience in the pharmaceutical and medical devices industry in both mature and emerging markets. Before joining the company, he spent several years within Novartis, first as Head of HR OTC for Europe at Novartis Consumer Health, and then as Head of HR for Europe, Middle East and Africa at Alcon. He also worked at Medtronic for five years, including as VP for Human Resources, Europe, Middle East & Africa and Canada – and at Bristol-Myers Squibb in different national and international HR leadership roles. CHIEF FINANCIAL OFFICER AND EVP CORPORATE STRATEGY, M&A, IT, GBS AND INDIRECT PROCUREMENT Susanne Larsson Susanne, a Swedish national, joined the executive team in March 2020. Most recently she held the role of Group CFO at Gunnebo – a multinational security company, listed on NASDAQ Stockholm. Before that she spent more than 20 years at the Gothenburg-based SKF group in various financial and strategic leadership positions. Susanne has extensive experience from driving growth and efficiency in global companies, including finance leadership, business control, governance and process development. At Mölnlycke she is responsible for Finance, IT and Business Development functions. Our Board Our board Mölnlycke Health Care is owned (98%) by Investor AB. We operate under a nine-member board of directors. The board consists of seven independent members, our CEO and one member from Investor AB. The chairman is one of the independent board members. Investor AB has owned Mölnlycke since 2007 INVESTOR AB We are 99% owned by Patricia Industries – part of Investor AB Investor AB is a leading owner of Nordic-based international companies, founded by the Wallenberg family in 1916. Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. We use cookies to improve your use and experience of Mölnlycke’s websites. By continuing to browse Mölnlycke’s site(s), you consent to the use of cookies in accordance with Mölnlycke’s applicable policies. © 2021 Mölnlycke Health Care AB. All rights reserved. Get to know us About us Products and solutions Our knowledge External links Contact us Get the details Regulatory support Products Instruction for use Media and press Policies Terms of use Cookie policy Follow Us Attention: Products shown on the Mölnlycke web sites(s) may not be available in all markets and product indication claim(s) may vary between markets. The Mölnlycke, Alldress, Arthropad, Avance, BARRIER, Biogel, Biogel Eclipse, Biogel PI Pro-Fit, Biogel Sensor, Brevet TX, Collar'n'Cuff, Drisite Easywarm, Elset, Epaderm, Exufiber, Granulox, Granudacyn, Hydrolock, EZ Derm, Hacdil, Hibi, Hibiclens, Hibidil, HiBiscrub, Indicator, Lyofoam, Mefix, Melgisorb, Mextra, Mepiform, Mepilex, Mepiseal, Mepitac, Mepitel, Mepore, Mesalt, Mesoft, Mesorb, Mestopore, Micro Indicator, NeoDerm, Normlgel, PI Indicator, PI Micro Indicator, PI Ultratouch, Polysling, Previsense, Reveal, Safetac, Setopress, Skinsense, Slinky, Steripod, Sterets, Tisept, Tubifast, Tubifast 2-way stretch, Tubigrip, Tubinette, Unisept and Unisoft trademarks, names and logos are registered globally to one or more of the Mölnlycke Health Care group of companies. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie policy Strictly Necessary Cookies Performance Cookies Targeting Cookies Cookies Settings Save Choices Accept All Cookies